{"id":"W2951331135","doi":"10.1097/01.hs9.0000562572.63485.4f","title":"PS1070 THE ECHELON‐2 TRIAL: RESULTS OF A RANDOMIZED, DOUBLE‐BLIND PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN AND CHP (A+CHP) VERSUS CHOP IN FRONTLINE TREATMENT OF PATIENTS WITH CD30+ PERIPHERAL T‐CELL LYMPHOMAS","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Brentuximab vedotin; CHOP; Internal medicine; Prednisone; Vincristine; Anaplastic large-cell lymphoma; Cyclophosphamide; Oncology; CD30; Lymphoma; Gastroenterology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002549766,0.001757633,0.002251941,0.0003646151,0.0003513639,0.001312858,0.0009477161,0.001578184,0.005603725],"category_scores_gemma":[0.001897792,0.0005840415,0.001890655,0.0003147613,0.001192796,0.001550511,0.0004312494,0.003902721,0.00120437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008673791,"about_ca_system_score_gemma":0.0008283427,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005777896,"about_ca_topic_score_gemma":0.001260914,"domain_scores_codex":[0.9991896,0.0004931316,0.0000368316,0.0001254972,0.0000572825,0.00009769726],"domain_scores_gemma":[0.9988469,0.0003604829,0.0002465675,0.0001163577,0.00007035307,0.0003593342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9823421,0.004004432,0.0003883461,0.0003413475,0.000674259,0.00003369028,0.00003806406,0.0003030704,0.001616486,0.00007732301,0.0007146948,0.009466218],"study_design_scores_gemma":[0.9568422,0.0405198,0.001236731,0.00002075411,0.00030671,0.00003301961,0.00001372161,0.0003274733,0.0002051613,0.0001387594,0.00034425,0.00001127641],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863769,0.004178345,0.0006403414,0.0009304531,0.0006367255,0.002522211,0.001631646,0.0001454095,0.002937998],"genre_scores_gemma":[0.985153,0.002212742,0.001274098,0.00163073,0.0005826579,0.002935255,0.002428342,0.00005070455,0.003732556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005603725,"threshold_uncertainty_score":0.01874638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02508550920323259,"score_gpt":0.2964247673137847,"score_spread":0.2713392581105521,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}